IL87265A0 - Free fatty acids for treatment or prophylaxis of rheumatoid arthritis - Google Patents

Free fatty acids for treatment or prophylaxis of rheumatoid arthritis

Info

Publication number
IL87265A0
IL87265A0 IL87265A IL8726588A IL87265A0 IL 87265 A0 IL87265 A0 IL 87265A0 IL 87265 A IL87265 A IL 87265A IL 8726588 A IL8726588 A IL 8726588A IL 87265 A0 IL87265 A0 IL 87265A0
Authority
IL
Israel
Prior art keywords
prophylaxis
treatment
fatty acids
rheumatoid arthritis
free fatty
Prior art date
Application number
IL87265A
Other languages
English (en)
Original Assignee
Century Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Century Lab Inc filed Critical Century Lab Inc
Publication of IL87265A0 publication Critical patent/IL87265A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL87265A 1987-08-07 1988-07-29 Free fatty acids for treatment or prophylaxis of rheumatoid arthritis IL87265A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/082,701 US4843095A (en) 1987-08-07 1987-08-07 Free fatty acids for treatment or propyhlaxis of rheumatoid arthritis arthritis

Publications (1)

Publication Number Publication Date
IL87265A0 true IL87265A0 (en) 1988-12-30

Family

ID=22172864

Family Applications (1)

Application Number Title Priority Date Filing Date
IL87265A IL87265A0 (en) 1987-08-07 1988-07-29 Free fatty acids for treatment or prophylaxis of rheumatoid arthritis

Country Status (9)

Country Link
US (1) US4843095A (de)
EP (1) EP0302482A3 (de)
JP (1) JPS6466118A (de)
AU (1) AU2048288A (de)
DK (1) DK440388A (de)
FI (1) FI883659A7 (de)
HU (1) HU200686B (de)
IL (1) IL87265A0 (de)
ZA (1) ZA885433B (de)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8804188D0 (en) * 1988-02-23 1988-03-23 Croda Int Plc Pharmaceutical compositions
US5407957A (en) * 1990-02-13 1995-04-18 Martek Corporation Production of docosahexaenoic acid by dinoflagellates
DK0457950T3 (da) * 1990-05-23 1994-03-07 Nestle Sa Anvendelse af stearidonsyre til behandling af inflammatorisk betingede sygdomme
GB9012651D0 (en) * 1990-06-06 1990-07-25 Efamol Holdings Essential fatty acid treatment
EP0568606B1 (de) * 1991-01-24 2001-04-18 Martek Corporation Mikrobielle öle und ihre verwendungen
CA2151820C (en) * 1993-01-15 2000-11-28 Stephen Joseph Demichele Structured lipids
US20050027004A1 (en) * 1993-06-09 2005-02-03 Martek Biosciences Corporation Methods of treating senile dementia and Alzheimer's diseases using docosahexaenoic acid and arachidonic acid compositions
US5411988A (en) * 1993-10-27 1995-05-02 Bockow; Barry I. Compositions and methods for inhibiting inflammation and adhesion formation
CA2240165A1 (en) * 1995-12-11 1997-06-19 Inholtra, Inc. Dietary regimen of nutritional supplements for relief of symptoms of arthritis
US5840715A (en) * 1995-12-11 1998-11-24 Inholtra Investment Holdings & Trading, N.V. Dietary regimen of nutritional supplements for relief of symptoms of arthritis
DE19629433A1 (de) * 1996-07-22 1998-01-29 Hoechst Ag Omega-3-fettsäurenenthaltende Zubereitung aus Mikroorganismen als Prophylaktikum bzw. Therapeutikum gegen parasitäre Erkrankungen beim Tier
US6051754A (en) * 1997-04-11 2000-04-18 Abbott Laboratories Methods and compositions for synthesis of long chain poly-unsaturated fatty acids in plants
US7745694B1 (en) 1997-04-11 2010-06-29 Monsanto Technology Llc Methods and compositions for synthesis of long chain polyunsaturated fatty acids in plants
US6075183A (en) * 1997-04-11 2000-06-13 Abbott Laboratories Methods and compositions for synthesis of long chain poly-unsaturated fatty acids in plants
US5968809A (en) 1997-04-11 1999-10-19 Abbot Laboratories Methods and compositions for synthesis of long chain poly-unsaturated fatty acids
US5972664A (en) * 1997-04-11 1999-10-26 Abbott Laboratories Methods and compositions for synthesis of long chain poly-unsaturated fatty acids
US6180671B1 (en) 1998-03-10 2001-01-30 Beth Israel Deaconess Medical Center, Inc. Methods for treating disorders in which docosahexaenoic acid (DHA) levels are affected
US6136795A (en) * 1998-11-18 2000-10-24 Omni Nutraceuticals, Inc Dietary regimen of nutritional supplements for relief of symptoms of arthritis
GB9901809D0 (en) 1999-01-27 1999-03-17 Scarista Limited Highly purified ethgyl epa and other epa derivatives for psychiatric and neurological disorderes
WO2001051598A1 (en) 2000-01-11 2001-07-19 Monsanto Technology Llc Process for making an enriched mixture of polyunsaturated fatty acid esters
ATE419858T1 (de) * 2001-06-18 2009-01-15 Neptune Technologies & Bioress Krillextrakte zur prävention und/oder behandlung von herz-kreislauf-erkrankungen
WO2004091603A1 (fr) * 2003-04-07 2004-10-28 Clinigenetics Utilisation d’un ester de dha pour le traitement des malades cardiovasculaires
US8633246B2 (en) * 2003-08-11 2014-01-21 Hill's Pet Nutrition, Inc. Omega-3 fatty acids for osteoarthritis
US8633247B2 (en) * 2003-08-11 2014-01-21 Hill's Pet Nutrition, Inc. Method for decreasing cartilage damage in dogs
US8075910B2 (en) * 2004-05-20 2011-12-13 Pbm Pharmaceuticals, Inc. Oral compositions comprising edible oils and vitamins and/or minerals and methods for making oral compositions
RU2396073C2 (ru) * 2004-11-29 2010-08-10 Унилевер Нв Пероральная композиция для улучшения свойств кожи
US20060286199A1 (en) * 2005-06-03 2006-12-21 Marilou Laprise Method and composition for increasing omega-3 lipid in milk
WO2007116027A1 (en) * 2006-04-12 2007-10-18 Unilever Plc Oral composition comprising a polyunsaturated fatty acid and salicylic acid for obtaining an antiinflammatory effect in skin
US20090239945A1 (en) * 2006-04-12 2009-09-24 John Casey Oral Composition with an Antiageing Effect on the Skin
US20080058418A1 (en) * 2006-09-06 2008-03-06 The Coca-Cola Company Stable polyunsaturated fatty acid emulsions and methods for inhibiting, suppressing, or reducing degradation of polyunsaturated fatty acids in an emulsion
US20090018186A1 (en) * 2006-09-06 2009-01-15 The Coca-Cola Company Stable beverage products comprising polyunsaturated fatty acid emulsions
DE102007055344A1 (de) * 2007-11-19 2009-05-20 K. D. Pharma Bexbach Gmbh Neue Verwendung von Omega-3-Fettsäure(n)
PL2334295T3 (pl) 2008-09-02 2017-12-29 Amarin Pharmaceuticals Ltd Kompozycja farmaceutyczna zawierająca kwas eikozapentaenowy i kwas nikotynowy oraz sposoby jej zastosowania
KR20140007973A (ko) 2009-02-10 2014-01-20 아마린 파마, 인크. 고중성지방혈증 치료 방법
BRPI1009431A2 (pt) * 2009-03-09 2016-03-01 Pronova Biopharma Norge As pré-concentrados farmacêuticos e de suplemento alimentar, sistemas de liberação de droga, método de tratamento de pelo menos um problema de saúde em sujeito em necessidade do mesmo e método e sistema
KR101759353B1 (ko) 2009-04-17 2017-07-18 나타크 파마 에스.엘 오메가-3 지방산이 풍부하고 피탄산 함량이 적은 조성물
SG10201912687WA (en) 2009-04-29 2020-02-27 Amarin Pharmaceuticals Ie Ltd Stable Pharmaceutical Composition And Methods Of Using Same
CN104042617A (zh) 2009-04-29 2014-09-17 阿马里纳药物爱尔兰有限公司 含有epa和心血管剂的药物组合物以及使用其的方法
EP3698781A1 (de) 2009-06-15 2020-08-26 Amarin Pharmaceuticals Ireland Limited Zusammensetzungen mit eicosapentaensäure zur behandlung von myokardinfarktionen bei patienten mit gleichzeitiger statin-therapie
RU2758369C2 (ru) 2009-09-23 2021-10-28 Амарин Фармасьютикалз Айрлэнд Лимитед Фармацевтическая композиция, включающая омега-3 жирную кислоту и гидроксипроизводное статина, и способы ее применения
KR101204748B1 (ko) * 2009-12-17 2012-11-26 (주) 켐포트 고도 불포화 지방산을 고농도로 함유하는 트리글리세라이드 유지의 제조방법
US20130137767A1 (en) * 2010-02-02 2013-05-30 Dsm Ip Assets B.V. Methods and Compositions for Treating Arthritis with Docosahexaenoic Acid
KR20130139896A (ko) * 2010-09-08 2013-12-23 프로노바 바이오파마 너지 에이에스 유리산 형태의 epa 및 dha, 계면활성제, 및 스타틴을 포함하는 조성물
NZ744990A (en) 2010-11-29 2019-10-25 Amarin Pharmaceuticals Ie Ltd Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
US11712429B2 (en) 2010-11-29 2023-08-01 Amarin Pharmaceuticals Ireland Limited Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
US11291643B2 (en) 2011-11-07 2022-04-05 Amarin Pharmaceuticals Ireland Limited Methods of treating hypertriglyceridemia
WO2013070735A1 (en) 2011-11-07 2013-05-16 Amarin Pharmaceuticals Ireland Limited Methods of treating hypertriglyceridemia
US9827219B2 (en) 2012-01-06 2017-11-28 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering levels of high-sensitivity C-reactive protein (HS-CRP) in a subject
RS57777B1 (sr) 2012-01-06 2018-12-31 Omthera Pharmaceuticals Inc Dpa-obogaćene kompozicije omega-3 polinezasićenih masnih kiselina u obliku slobodne kiseline
HK1206248A1 (en) 2012-05-07 2016-01-08 Omthera Pharmaceuticals Inc. Compositions of statins and omega-3 fatty acids
LT4338805T (lt) 2012-06-29 2025-09-25 Amarin Pharmaceuticals Ireland Limited Eikozapentaeno rūgšties etilo esteris, skirtas panaudoti mažinant nemirtino miokardo infarkto riziką subjektui, gydomam statinais
US20150265566A1 (en) 2012-11-06 2015-09-24 Amarin Pharmaceuticals Ireland Limited Compositions and Methods for Lowering Triglycerides without Raising LDL-C Levels in a Subject on Concomitant Statin Therapy
US9814733B2 (en) 2012-12-31 2017-11-14 A,arin Pharmaceuticals Ireland Limited Compositions comprising EPA and obeticholic acid and methods of use thereof
US20140187633A1 (en) 2012-12-31 2014-07-03 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary cirrhosis
US9452151B2 (en) 2013-02-06 2016-09-27 Amarin Pharmaceuticals Ireland Limited Methods of reducing apolipoprotein C-III
US9624492B2 (en) 2013-02-13 2017-04-18 Amarin Pharmaceuticals Ireland Limited Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof
US9662307B2 (en) 2013-02-19 2017-05-30 The Regents Of The University Of Colorado Compositions comprising eicosapentaenoic acid and a hydroxyl compound and methods of use thereof
US9283201B2 (en) 2013-03-14 2016-03-15 Amarin Pharmaceuticals Ireland Limited Compositions and methods for treating or preventing obesity in a subject in need thereof
US20140271841A1 (en) 2013-03-15 2014-09-18 Amarin Pharmaceuticals Ireland Limited Pharmaceutical composition comprising eicosapentaenoic acid and derivatives thereof and a statin
US10966968B2 (en) 2013-06-06 2021-04-06 Amarin Pharmaceuticals Ireland Limited Co-administration of rosiglitazone and eicosapentaenoic acid or a derivative thereof
US20150065572A1 (en) 2013-09-04 2015-03-05 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing prostate cancer
US9585859B2 (en) 2013-10-10 2017-03-07 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy
US10561631B2 (en) 2014-06-11 2020-02-18 Amarin Pharmaceuticals Ireland Limited Methods of reducing RLP-C
US10172818B2 (en) 2014-06-16 2019-01-08 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids
US10406130B2 (en) 2016-03-15 2019-09-10 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids
TW201900160A (zh) 2017-05-19 2019-01-01 愛爾蘭商艾瑪琳製藥愛爾蘭有限公司 用於降低腎功能下降之個體中的三酸甘油酯之組合物及方法
US11058661B2 (en) 2018-03-02 2021-07-13 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides in a subject on concomitant statin therapy and having hsCRP levels of at least about 2 mg/L
EP3750535B1 (de) 2018-09-24 2025-12-31 Amarin Pharmaceuticals Ireland Limited Verfahren zur verringerung des risikos von kardiovaskulären ereignissen in einem subjekt
BR112022009189A2 (pt) 2019-11-12 2022-07-26 Amarin Pharmaceuticals Ie Ltd Métodos para reduzir o risco de eventos cardiovasculares em um sujeito com fibrilação atrial e/ou palpitação atrial
AU2022263358A1 (en) 2021-04-21 2023-11-30 Amarin Pharmaceuticals Ireland Limited Methods of reducing the risk of heart failure

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4273763A (en) * 1978-01-23 1981-06-16 Efamol Limited Pharmaceutical and dietary compositions
GB1604554A (en) * 1978-05-26 1981-12-09 Dyerberg J Pharmaceutical and food formulations
GB2033745B (en) * 1978-05-26 1983-08-17 Wellcome Found Fatty acid and derivatives thereof for use in treatment or prophylaxis of thromboembolic conditions
US4472432A (en) * 1982-05-12 1984-09-18 Inabata & Co., Ltd. Medicinal use of α,β-unsaturated fatty acids
US4512996A (en) * 1982-12-13 1985-04-23 Lowell Somers Benzoylecgonine or benzoylnorecgonine as active agents for the treatment of rheumatoid arthritis
US4526902A (en) * 1983-10-24 1985-07-02 Century Laboratories, Inc. Combined fatty acid composition for treatment or prophylaxis of thrombo-embolic conditions
CA1239587A (en) * 1983-10-24 1988-07-26 David Rubin Combined fatty acid composition for lowering blood cholestrol and triglyceride levels
GB8507058D0 (en) * 1985-03-19 1985-04-24 Efamol Ltd Pharmaceutical & dietary compositions

Also Published As

Publication number Publication date
HUT47426A (en) 1989-03-28
FI883659L (fi) 1989-02-08
FI883659A7 (fi) 1989-02-08
DK440388A (da) 1989-02-08
ZA885433B (en) 1989-03-29
EP0302482A2 (de) 1989-02-08
FI883659A0 (fi) 1988-08-05
JPS6466118A (en) 1989-03-13
HU200686B (en) 1990-08-28
US4843095A (en) 1989-06-27
AU2048288A (en) 1989-02-09
DK440388D0 (da) 1988-08-05
EP0302482A3 (de) 1990-08-22

Similar Documents

Publication Publication Date Title
IL87265A0 (en) Free fatty acids for treatment or prophylaxis of rheumatoid arthritis
EP0278745A3 (en) Process for the treatment of waste
EP0293748A3 (en) Process for the preparation of 2(5h)-furanones
GB8704089D0 (en) Method of treatment
GB2219503B (en) Treatment of arthritis
HUT49150A (en) Process for precipitation of vancomicine
GB8704532D0 (en) Treatment of froth
EP0300982A3 (en) Treatment of infertility
JPS6440446A (en) Manufacture of dicyclopentenol ester
EP0420428A3 (en) Method of treatment of rheumatoid arthritis using phytic acid
GB2206341B (en) Treatment of organically-based waste matter
HUT48560A (en) Process for reduction of metonin-sulphoxid groups
IL83251A0 (en) Process for the separation of acids and their corresponding metal salts
GB2209750B (en) Process for the manufacture of higher fatty monoglyceride monosulphate detergents
GB8501617D0 (en) Mechanical treatment of workpieces
PL265374A1 (en) Method of obtaining aminophosphonic esters
GB8610698D0 (en) Treatment of rheumatoid arthritis
PL265590A2 (en) Method of purifying raw 2-methoxycarbonyl-amino-benzimidazole-5-/6/-phenylthioester
CS252587A1 (en) Process for the stabilization of neutralization sludge
GB8403142D0 (en) Treatment of rheumatoid arthritis
RU1785688C (ru) Cпocoб лeчehия пcopиatичeckoгo aptpиta
IE870715L (en) Purification of glycolide
PL268985A1 (en) Method of obtaining -amino-/3-alkylphenyl/alkylacetic acids
GB8531418D0 (en) Treatment of rheumatoid arthritis
BG44101A1 (en) Method for processing of phosphogypsum